Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invivo Therapeutics Holdings Corp (NVIV)

Invivo Therapeutics Holdings Corp (NVIV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Invivo Therapeutics Holdings Corp ONE KENDALL SQUARE SUITE B14402 CAMBRIDGE MA 02139 USA

P: 617-863-5500

Description:

InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 5,596
Shares Outstanding, K 9,312
Annual Sales, $ 0 K
Annual Net Income, $ -23,420 K
60-Month Beta 1.43
% of Insider Shareholders 0.30%
% of Institutional Shareholders 7.54%
Float, K 9,284
% Float 99.70%

Growth:

1-Year Return -67.57%
3-Year Return -99.68%
5-Year Return -99.10%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 91.35%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/20/19
Earnings Per Share ttm -0.70
EPS Growth vs. Prev Year 91.62%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-25 on 04/17/18

NVIV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -0.17
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -78.39
Return-on-Assets (Before Tax) -65.23
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.09
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.53
Book Value/Share 1.12
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar